Can better cognitive testing platforms accelerate pharma’s Alzheimer’s research and development efforts?

By SharpBrains | May 4, 2015

. Alzheimer’s cure behind the boom in brain sci­ence (Finan­cial Review): “Bio­gen is one of many mem­bers of big phar­ma seek­ing the block­buster drug which will inevitably be worth mul­ti­ple bil­lions of dol­lars. Big phar­ma in the US spends about $US5 bil­lion a year on Alzheimer’s research and devel­op­ment. Expo­nen­tial growth in the dis­ease over…

Read More